Kweichow Moutai stock price: 600519 slips again as China readies leverage curbs and GDP week
17 January 2026
1 min read

Kweichow Moutai stock price: 600519 slips again as China readies leverage curbs and GDP week

Shanghai, Jan 18, 2026, 04:16 GMT+8 — Market closed.

Kweichow Moutai Co Ltd’s Class A shares (600519.SS) closed Friday down 0.5% at 1,382 yuan. Mainland markets are closed for the weekend, leaving investors to digest fresh leverage restrictions alongside a packed China data calendar ahead of the next session. 1

The baijiu maker stands out as a preferred proxy for domestic consumption and a reliable go-to when traders seek size and liquidity without jumping on the latest trends. This positioning makes it vulnerable to changes in risk appetite and any signals from headline economic data.

It still holds significant clout. By Friday’s close, the company’s market cap stood at roughly 1.73 trillion yuan, securing its spot as one of the Shanghai market’s top players. 2

On Friday, the stock fluctuated between 1,380 yuan and 1,397.5 yuan, with roughly 5.51 million shares traded. It’s been down four sessions in a row, dropping every day since Jan. 13. 3

Regulators are moving to cool the market. China’s securities regulator announced plans to ramp up oversight and clamp down on “excessive speculation” as the Shanghai Composite neared a 10-year peak and trading volume hit record highs this week. Stock exchanges will raise the minimum margin requirement for new loans from 80% to 100%, effective Jan. 19. 4

Margin trading means buying shares using borrowed funds. When margin requirements rise, investors must commit more cash to open new leveraged positions, which can quickly drain turnover if traders are already stretched thin.

Moutai remains fixated on three things: demand, pricing discipline, and the strength of its distribution network. Baijiu, China’s potent grain spirit, often sees Moutai’s top-tier bottles serve as a quick gauge of consumer confidence when the broader economic outlook gets uncertain.

The risk is that stricter leverage rules weigh on liquidity more than anticipated, dragging down even the market’s top defensive stocks. Should upcoming data fall short, consumer bellwethers could see sharp markdowns, particularly since they trade at the pricey end of the market by share price.

Monday brings the latest data. Chris Williamson, chief business economist at S&P Global Market Intelligence, said China’s mainland GDP for Q4 is expected to show a 4.5% annual rise. Along with that, December figures for industrial output, retail sales, and fixed-asset investment will be released. China’s Loan Prime Rate announcement follows on Tuesday. 5

Stock Market Today

Strive Asset Management (ASST) stock price jumps after 1-for-20 reverse split — what investors watch next

7 February 2026
NEW YORK, Feb 7, 2026, 10:06 ET — Market closed. Shares of Strive, Inc. (ASST) jumped 20.8% on Friday and closed at $11.915, the first regular session after a 1-for-20 reverse stock split took effect ahead of the open. The stock ranged from $9.35 to $12.25, with 9.36 million shares traded, according to market data. 1 With U.S. markets shut for the weekend, the next test is Monday’s open: whether the higher share price brings in steadier buying, or just resets the tape for another bout of sharp swings. Reverse splits bundle shares — 20 become one — lifting the
Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
American Express (AXP) stock price rises ahead of rate-cap week — what investors watch next
Previous Story

American Express (AXP) stock price rises ahead of rate-cap week — what investors watch next

International Holding Company (IHC) stock holds near 400 AED as Lukoil talks drag on — what to watch next
Next Story

International Holding Company (IHC) stock holds near 400 AED as Lukoil talks drag on — what to watch next

Go toTop